Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
102.45B | 109.20B | 104.60B | 90.64B | 73.59B | 74.15B | Gross Profit |
16.06B | 16.87B | 16.08B | 13.04B | 12.07B | 11.81B | EBIT |
8.44B | 8.86B | 8.34B | 5.58B | 4.86B | 5.11B | EBITDA |
12.21B | 14.01B | 13.63B | 9.46B | 8.99B | 9.22B | Net Income Common Stockholders |
5.94B | 5.94B | 5.89B | 5.37B | 3.87B | 3.70B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
44.58B | 47.58B | 43.29B | 39.47B | 34.82B | 32.68B | Total Assets |
109.29B | 115.53B | 106.81B | 100.36B | 89.20B | 84.87B | Total Debt |
0.00 | 215.00M | 105.00M | 1.63B | 1.62B | 1.62B | Net Debt |
-44.58B | -47.36B | -43.19B | -37.83B | -33.20B | -31.06B | Total Liabilities |
20.97B | 23.26B | 20.75B | 21.33B | 17.18B | 17.38B | Stockholders Equity |
85.37B | 88.92B | 82.98B | 76.11B | 69.69B | 65.00B |
Cash Flow | Free Cash Flow | ||||
0.00 | 5.61B | 8.21B | 4.86B | 3.33B | 4.89B | Operating Cash Flow |
0.00 | 9.84B | 11.92B | 7.77B | 6.03B | 8.38B | Investing Cash Flow |
0.00 | -4.50B | -2.97B | -2.62B | -2.62B | -2.56B | Financing Cash Flow |
0.00 | -3.05B | -6.17B | -2.26B | -2.22B | -1.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥73.61B | 5.92 | 5.84% | -1.56% | -5.89% | ||
79 Outperform | ¥68.79B | 11.76 | 3.97% | 4.40% | 3.95% | ||
72 Outperform | ¥79.24B | 5.70 | 3.98% | -0.59% | -20.67% | ||
69 Neutral | ¥62.31B | 7.23 | 5.25% | -0.69% | 8.49% | ||
63 Neutral | $6.98B | 11.41 | 2.80% | 4.24% | 2.68% | -24.94% | |
61 Neutral | ¥59.97B | 34.81 | 5.78% | -1.86% | -55.33% | ||
61 Neutral | ¥64.13B | 10.32 | 0.84% | -11.15% | -51.63% |